166 related articles for article (PubMed ID: 35753782)
1. Expression of L-type amino acid transporter 1 in canine and feline intracranial tumors.
Utsugi S; Ogihara K; Naya Y; Sunden Y; Nakamoto Y; Okamoto Y
J Vet Med Sci; 2022 Aug; 84(8):1111-1117. PubMed ID: 35753782
[TBL] [Abstract][Full Text] [Related]
2. L-type amino acid transporter 1 (LAT1) expression in canine mammary gland tumors.
Fukumoto S; Hanazono K; Komatsu T; Iwano H; Kadosawa T; Uchide T
J Vet Med Sci; 2013 May; 75(4):431-7. PubMed ID: 23171689
[TBL] [Abstract][Full Text] [Related]
3. L-type amino acid transporter 1 (LAT1): a new therapeutic target for canine mammary gland tumour.
Fukumoto S; Hanazono K; Komatsu T; Ueno H; Kadosawa T; Iwano H; Uchide T
Vet J; 2013 Oct; 198(1):164-9. PubMed ID: 23896327
[TBL] [Abstract][Full Text] [Related]
4. A new treatment for human malignant melanoma targeting L-type amino acid transporter 1 (LAT1): a pilot study in a canine model.
Fukumoto S; Hanazono K; Fu DR; Endo Y; Kadosawa T; Iwano H; Uchide T
Biochem Biophys Res Commun; 2013 Sep; 439(1):103-8. PubMed ID: 23954667
[TBL] [Abstract][Full Text] [Related]
5. Correlation of L-methyl-11C-methionine (MET) uptake with L-type amino acid transporter 1 in human gliomas.
Okubo S; Zhen HN; Kawai N; Nishiyama Y; Haba R; Tamiya T
J Neurooncol; 2010 Sep; 99(2):217-25. PubMed ID: 20091333
[TBL] [Abstract][Full Text] [Related]
6. Canine Lat1: molecular structure, distribution and its expression in cancer samples.
Ochiai H; Morishita T; Onda K; Sugiyama H; Maruo T
J Vet Med Sci; 2012 Jul; 74(7):917-22. PubMed ID: 22322188
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
[TBL] [Abstract][Full Text] [Related]
8. Expression of L-type amino acid transporter 1 is a poor prognostic factor for Non-Hodgkin's lymphoma.
Jigjidkhorloo N; Kanekura K; Matsubayashi J; Akahane D; Fujita K; Oikawa K; Kurata A; Takanashi M; Endou H; Nagao T; Gotoh A; Norov O; Kuroda M
Sci Rep; 2021 Nov; 11(1):21638. PubMed ID: 34737339
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of large amino acid transporter type 1 (LAT1) expression in pulmonary adenocarcinoma: A tissue microarray study.
Terao A; Ninomiya H; Takeuchi K
Cancer Treat Res Commun; 2024; 39():100814. PubMed ID: 38677033
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of CD34, E-cadherin, claudin-1, glucose transporter 1, laminin, and protein gene product 9.5 in 28 canine and 8 feline meningiomas.
Ramos-Vara JA; Miller MA; Gilbreath E; Patterson JS
Vet Pathol; 2010 Jul; 47(4):725-37. PubMed ID: 20403881
[TBL] [Abstract][Full Text] [Related]
11. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
[TBL] [Abstract][Full Text] [Related]
12. The Role of Large Neutral Amino Acid Transporter (LAT1) in Cancer.
Lu X
Curr Cancer Drug Targets; 2019; 19(11):863-876. PubMed ID: 31376820
[TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
14. Analysis of L-type amino acid transporter in canine hepatocellular carcinoma.
Ogihara K; Naya Y; Sato R; Onda K; Ochiai H
J Vet Med Sci; 2015 May; 77(5):527-34. PubMed ID: 25649314
[TBL] [Abstract][Full Text] [Related]
15. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
Kanai Y
Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
[TBL] [Abstract][Full Text] [Related]
16. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Ooigawa H; Shima K; Matsuo H; Kanai Y; Endou H
Int J Cancer; 2006 Aug; 119(3):484-92. PubMed ID: 16496379
[TBL] [Abstract][Full Text] [Related]
17. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.
Koshi H; Sano T; Handa T; Yanagawa T; Saitou K; Nagamori S; Kanai Y; Takagishi K; Oyama T
Pathol Int; 2015 Sep; 65(9):460-7. PubMed ID: 26134029
[TBL] [Abstract][Full Text] [Related]
18. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas.
Yanagisawa N; Ichinoe M; Mikami T; Nakada N; Hana K; Koizumi W; Endou H; Okayasu I
J Clin Pathol; 2012 Nov; 65(11):1019-23. PubMed ID: 22813728
[TBL] [Abstract][Full Text] [Related]
19. The RNA interference of amino acid transporter LAT1 inhibits the growth of KB human oral cancer cells.
Kim CH; Park KJ; Park JR; Kanai Y; Endou H; Park JC; Kim DK
Anticancer Res; 2006; 26(4B):2943-8. PubMed ID: 16886618
[TBL] [Abstract][Full Text] [Related]
20. Evidence of LAT1 expression in canine caput epididymis.
Ogihara K; Onda K; Sato R; Naya Y; Ochiai H
J Vet Med Sci; 2015 Jan; 77(1):85-8. PubMed ID: 25252639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]